Filing Details

Accession Number:
0001104659-13-043964
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-22 17:30:46
Reporting Period:
2013-05-21
Filing Date:
2013-05-22
Accepted Time:
2013-05-22 17:30:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130166 Cyclacel Pharmaceuticals Inc. CYCC Pharmaceutical Preparations (2834) 911766850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1357396 George Spiro Rombotis 200 Connell Drive, Suite 1500
Berkeley Heights NJ 07922
President & C.e.o. Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2013-05-21 100,000 $3.00 268,292 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The total number of shares of common stock beneficially owned by the Reporting Person has been reduced due to an inadvertent mathematical error in a prior report. Of the shares of common stock reported, 142 shares are held indirectly by Mr. Rombotis through his IRA account and 30,714 shares are represented by unvested restricted stock units.